id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-E-0114-0003,FDA,FDA-2011-E-0114,FDA/CDER to U.S. Patent and Trademari Office - Letter,Other,LET-Letter,2011-04-25T04:00:00Z,2011,4,2011-04-25T04:00:00Z,,2011-04-25T19:24:53Z,,0,0,0900006480c37dcb
FDA-2011-E-0114-0002,FDA,FDA-2011-E-0114,U.S. Patent and Trademark Office - Letter,Other,LET-Letter,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-07-27T23:46:05Z,,0,0,0900006480bf83ed
FDA-2011-E-0114-0001,FDA,FDA-2011-E-0114,"Novo Nordisk A/S c/o Novo Nordisk, Inc. (Richard W. Bork) - Patent Term Extension Application",Other,APP-Application,2011-02-25T05:00:00Z,2011,2,2011-02-25T05:00:00Z,,2013-07-27T23:46:04Z,,0,0,0900006480bf7cf5